Details for New Drug Application (NDA): 019543
✉ Email this page to a colleague
The generic ingredient in ELOCON is mometasone furoate. There are thirty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 019543
Tradename: | ELOCON |
Applicant: | Merck Sharp Dohme |
Ingredient: | mometasone furoate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 019543
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 0.1% | ||||
Approval Date: | Apr 30, 1987 | TE: | RLD: | Yes |
Expired US Patents for NDA 019543
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck Sharp Dohme | ELOCON | mometasone furoate | OINTMENT;TOPICAL | 019543-001 | Apr 30, 1987 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription